查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1753904

血管移植市场报告（按产品、原料（聚四氟乙烯、聚酯、聚氨酯、生物合成材料）、应用、最终用户（医院、门诊手术中心）和地区）2025 年至 2033 年

Vascular Grafts Market Report by Product, Raw Material (Polytetrafluoroethylene, Polyester, Polyurethane, Biosynthetic), Application, End User (Hospitals, Ambulatory Surgical Centers ), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球血管移植市场规模达20亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到33亿美元，2025-2033年期间的复合年增长率（CAGR）为5.42%。致命道路交通事故和创伤病例的增加、医疗旅游需求的上升以及外科手术数量的增加（尤其是在老年人群体中），是推动市场发展的主要因素。

血管移植物是用来取代、搭桥或恢復人体受损或生病血管功能的医疗器材。它们作为人工导管，促进血液流动，确保重要器官和组织获得充足的血液供应。它们可以由多种材料製成，包括聚酯纤维和特氟隆等合成聚合物，以及从患者或供体采集的静脉段等生物材料。它们常用于外科手术，例如冠状动脉绕道手术 (CABG)、週边动脉绕道术和血液透析通路。

致命道路交通事故的增加和创伤病例的增加，推动了全球对血管移植的需求。此外，医疗旅游的兴起，人们纷纷前往医疗体系先进的国家接受包括血管移植手术在内的专科治疗，也有利于市场的成长。此外，外科手术数量的增加以及全球老年人口的增加（老年人口更容易患上疾病），也对市场产生了积极的影响。此外，预防性医疗保健日益受到重视，这有助于对血管疾病进行早期诊断和治疗，这催化了对血管移植作为预防措施的需求。此外，越来越多的门诊手术中心能够提供更快速、更便利的手术服务，也为市场带来了正面的前景。

血管移植市场趋势/驱动因素：

生活方式疾病盛行率上升

推动血管移植需求成长的主要因素之一是肥胖和糖尿病等生活方式相关疾病的盛行率激增。这些疾病显着增加了血管疾病的风险，而这些疾病可能需要进行移植手术。随着生活方式疾病的持续激增，用于治疗相关血管併发症的血管移植需求可能会大幅增加。

公众意识和教育水准的提高

大众对血管疾病及其现有治疗方案的认识不断提高，也刺激了对血管移植的需求。公共卫生运动、教育计画和数位平台正在向人们普及血管疾病的风险以及早期诊断和治疗的重要性。这种认知的提高促使更多人寻求医疗建议，从而增加了血管移植手术的数量。

不断增长的监管批准和报销政策

有利的监管审批和报销政策在推动血管移植市场发展方面发挥着至关重要的作用。许多国家的监管机构对包括血管移植在内的新型医疗器材的审批都制定了严格但明确的流程。一旦获得批准，这些产品更容易被医疗机构采用。此外，全面的报销政策使患者能够以经济实惠的方式选择这些先进的治疗方法，从而进一步提升了市场对血管移植的需求。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球血管移植市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 血管内支架移植物
  • 血液透析通路移植物
  • 冠状动脉绕道手术
  • 主动脉疾病的血管移植
  • 週边血管移植

第七章：市场区隔：依原料

  • 聚四氟乙烯（PTFE）
  • 聚酯纤维
  • 聚氨酯
  • 生物合成

第 8 章：市场区隔：按应用

  • 心臟动脉瘤
  • 肾衰竭
  • 血管闭塞
  • 冠状动脉疾病

第九章：市场区隔：依最终用户

  • 医院
  • 门诊手术中心（ASC）

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • B. Braun SE (B. Braun Holding GmbH & Co. KG)
    • Becton, Dickinson and Company
    • Cook Group Incorporated
    • Cordis
    • CryoLife Inc.
    • Getinge AB
    • Heat Medical Europe BV
    • LeMaitre Vascular
    • Medtronic plc
    • Terumo Corporation
    • WL Gore & Associates Inc.
Product Code: SR112025A6256

The global vascular grafts market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033. The increasing number of fatal road accidents and trauma cases, rising inclination towards medical tourism, and the growing number of surgical procedures, especially among the geriatric population, are some of the major factors propelling the market.

Vascular grafts are medical devices used to replace, bypass, or restore functionality to damaged or diseased blood vessels in the human body. They serve as artificial conduits that facilitate blood flow and ensure that vital organs and tissues receive adequate blood supply. They can be made from various materials, including synthetic polymers like dacron and teflon or biological materials like vein segments harvested from the patient or a donor. They are commonly used in surgical procedures, such as coronary artery bypass grafting (CABG), peripheral artery bypass, and hemodialysis access.

The increasing number of fatal road accidents and the expanding number of trauma cases are driving the demand for vascular grafts around the world. Moreover, the rising inclination towards medical tourism, wherein people are traveling to countries with advanced healthcare systems for specialized treatments, including vascular graft surgeries, is favoring the growth of the market. In addition, the growing number of surgical procedures and the rising global geriatric population, which is more susceptible to medical disorders, are influencing the market positively. Apart from this, the increasing focus on preventive healthcare, which leads to early diagnosis and treatment of vascular conditions, is catalyzing the need for vascular grafts as a preemptive measure. Furthermore, the growing number of ambulatory surgical centers, which offer quicker and more convenient surgical procedures, are creating a positive outlook for the market.

Vascular Grafts Market Trends/Drivers:

Increase in prevalence of lifestyle diseases

One of the primary factors that are driving the demand for vascular grafts is the surging prevalence of lifestyle-related diseases like obesity and diabetes. These conditions significantly elevate the risk of developing vascular problems that may necessitate graft surgeries. As lifestyle diseases continue to surge, the requirement for vascular grafts to manage associated vascular complications is likely to grow substantially.

Rise in public awareness and education

Increasing public awareness about vascular diseases and the available treatment options is also catalyzing thee demand for vascular grafts. Public health campaigns, educational programs, and digital platforms are educating people about the risks of vascular conditions and the importance of early diagnosis and treatment. This heightened awareness is leading to more people seeking medical advice and, consequently, increasing the number of vascular graft surgeries being performed.

Growing regulatory approvals and reimbursement policies

Favorable regulatory approvals and reimbursement policies play a crucial role in driving the market for vascular grafts. Regulatory bodies of numerous countries have stringent but clear pathways for the approval of new medical devices, including vascular grafts. Once approved, these products are more readily adopted by medical facilities. Additionally, comprehensive reimbursement policies make it financially feasible for patients to opt for these advanced treatments, further elevating the demand for vascular grafts in the market.

Vascular Grafts Industry Segmentation:

Breakup by Product:

  • Endovascular Stent Grafts
  • Hemodialysis Access Grafts
  • Coronary Artery By-Pass Grafts
  • Vascular Grafts for Aorta Disease
  • Peripheral Vascular Grafts

Endovascular stent grafts dominate the market

Hemodialysis access grafts serve a different purpose but are equally important in the field of medicine. They are used to provide reliable and durable vascular access for patients who require long-term hemodialysis, a treatment for kidney failure. Typically made of synthetic materials like PTFE (polytetrafluoroethylene), these grafts are surgically implanted to connect an artery to a vein, usually in the arm. Hemodialysis access grafts offer the advantage of immediate use, as opposed to AV fistulas that often require weeks to mature before they can be used for dialysis.

Breakup by Raw Material:

  • Polytetrafluoroethylene (PTFE)
  • Polyester
  • Polyurethane
  • Biosynthetic

Polytetrafluoroethylene (PTFE) holds the largest share in the market

Polyester is another widely used synthetic material in the construction of vascular grafts, particularly in applications like aortic and peripheral vascular bypass surgeries. Often sold under the brand name Dacron, polyester vascular grafts have been used for several decades and have a well-established safety and efficacy profile. Polyester is known for its excellent mechanical properties, including tensile strength and durability, which makes it a preferred choice for long-term implantation. It also possesses good biocompatibility and allows for tissue ingrowth, which helps in anchoring the graft securely in place over time.

Breakup by Application:

  • Cardiac Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Coronary Artery Disease

Cardiac aneurysm dominates the market

In the context of kidney failure, vascular grafts are commonly used to create a functional access point for hemodialysis. When a kidney fails of a patient to adequately filter blood, hemodialysis becomes necessary to remove waste products. Reliable vascular access is crucial for this process. Hemodialysis access grafts, often made from PTFE, are used to surgically connect an artery to a vein, usually in the arm. This connection, known as an arteriovenous (AV) graft, provides a high-flow circuit that facilitates efficient blood removal and return during dialysis sessions. These grafts are particularly useful for patients who cannot use an arteriovenous fistula, either due to poor vein quality or other medical considerations.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

Hospitals hold the largest share in the market

Ambulatory surgical centers (ASCs) also serve as significant end users of vascular grafts, although their scope may be more limited as compared to hospitals. ASCs are healthcare facilities wherein surgeries that do not require an overnight hospital stay are performed. Due to advancements in minimally invasive surgical (MIS) techniques, certain procedures involving vascular grafts, such as some types of endovascular stent placements, can now be conducted in these settings. ASCs offer the advantage of quicker patient turnover, lower cost, and a more streamlined patient experience.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest vascular grafts market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The surging prevalence of diabetes among the masses represents one of the primary factors bolstering the market growth in the North American region. Moreover, the rising adoption of cutting-edge diagnostic technologies like AI and advanced imaging is contributing to the market growth in the region. Besides this, the growing preference for MI surgeries is influencing the market positively.

Competitive Landscape:

The leading companies are developing bioengineered and drug-eluting grafts that aim to mitigate these drawbacks by incorporating living cells or biological molecules to improve biocompatibility and encourage tissue integration. They are also coated with pharmaceutical agents that are slowly released into the bloodstream, which reduces the risk of clot formation and vessel narrowing post-surgery. Moreover, key players are adopting the use of 3D printing technologies to create custom vascular grafts that match the specific anatomical needs of individual patients and reduce the risk of complications that can arise from ill-fitting grafts. They are also utilizing nanotechnology to offer unique mechanical and biological properties, which include better flexibility and reduced thrombogenicity.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • B. Braun SE (B. Braun Holding GmbH & Co. KG)
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Cordis
  • CryoLife Inc.
  • Getinge AB
  • Heat Medical Europe BV
  • LeMaitre Vascular
  • Medtronic plc
  • Terumo Corporation
  • W. L. Gore & Associates Inc.

Key Questions Answered in This Report

  • 1.How big is the global vascular grafts market?
  • 2.What is the expected growth rate of the global vascular grafts market during 2025-2033?
  • 3.What are the key factors driving the global vascular grafts market?
  • 4.What has been the impact of COVID-19 on the global vascular grafts market?
  • 5.What is the breakup of the global vascular grafts market based on the product?
  • 6.What is the breakup of the global vascular grafts market based on the raw material?
  • 7.What is the breakup of the global vascular grafts market based on the application?
  • 8.What is the breakup of the global vascular grafts market based on the end user?
  • 9.What are the key regions in the global vascular grafts market?
  • 10.Who are the key players/companies in the global vascular grafts market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vascular Grafts Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Endovascular Stent Grafts
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hemodialysis Access Grafts
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Coronary Artery By-Pass Grafts
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Vascular Grafts for Aorta Disease
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Peripheral Vascular Grafts
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Raw Material

  • 7.1 Polytetrafluoroethylene (PTFE)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polyester
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Polyurethane
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biosynthetic
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cardiac Aneurysm
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Kidney Failure
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Vascular Occlusion
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Coronary Artery Disease
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers (ASCs)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 B. Braun SE (B. Braun Holding GmbH & Co. KG)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Becton, Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cook Group Incorporated
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Cordis
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 CryoLife Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Getinge AB
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Heat Medical Europe BV
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 LeMaitre Vascular
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Medtronic plc
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Terumo Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 W. L. Gore & Associates Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Vascular Grafts Market: Major Drivers and Challenges
  • Figure 2: Global: Vascular Grafts Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Vascular Grafts Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Vascular Grafts Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Vascular Grafts Market: Breakup by Raw Material (in %), 2024
  • Figure 6: Global: Vascular Grafts Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Vascular Grafts Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Vascular Grafts Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Vascular Grafts (Endovascular Stent Grafts) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Vascular Grafts (Endovascular Stent Grafts) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Vascular Grafts (Hemodialysis Access Grafts) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Vascular Grafts (Hemodialysis Access Grafts) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Vascular Grafts (Coronary Artery By-Pass Grafts) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Vascular Grafts (Coronary Artery By-Pass Grafts) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Vascular Grafts (Vascular Grafts for Aorta Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Vascular Grafts (Vascular Grafts for Aorta Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Vascular Grafts (Peripheral Vascular Grafts) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Vascular Grafts (Peripheral Vascular Grafts) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Vascular Grafts (Polytetrafluoroethylene (PTFE)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Vascular Grafts (Polytetrafluoroethylene (PTFE)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Vascular Grafts (Polyester) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Vascular Grafts (Polyester) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Vascular Grafts (Polyurethane) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Vascular Grafts (Polyurethane) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Vascular Grafts (Biosynthetic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Vascular Grafts (Biosynthetic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Vascular Grafts (Cardiac Aneurysm) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Vascular Grafts (Cardiac Aneurysm) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Vascular Grafts (Kidney Failure) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Vascular Grafts (Kidney Failure) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Vascular Grafts (Vascular Occlusion) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Vascular Grafts (Vascular Occlusion) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Vascular Grafts (Coronary Artery Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Vascular Grafts (Coronary Artery Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Vascular Grafts (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Vascular Grafts (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Vascular Grafts (Ambulatory Surgical Centers (ASCs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Vascular Grafts (Ambulatory Surgical Centers (ASCs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: North America: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: United States: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: United States: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Canada: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Canada: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia-Pacific: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia-Pacific: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: China: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: China: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Japan: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Japan: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: India: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: India: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: South Korea: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: South Korea: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Australia: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Australia: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Indonesia: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Indonesia: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Europe: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Europe: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Germany: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Germany: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: France: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: France: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: United Kingdom: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: United Kingdom: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Italy: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Italy: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Spain: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Spain: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Russia: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Russia: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Latin America: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Latin America: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Brazil: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Brazil: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Mexico: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Mexico: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Middle East and Africa: Vascular Grafts Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Middle East and Africa: Vascular Grafts Market: Breakup by Country (in %), 2024
  • Figure 87: Middle East and Africa: Vascular Grafts Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Vascular Grafts Industry: SWOT Analysis
  • Figure 89: Global: Vascular Grafts Industry: Value Chain Analysis
  • Figure 90: Global: Vascular Grafts Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vascular Grafts Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Vascular Grafts Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Vascular Grafts Market Forecast: Breakup by Raw Material (in Million USD), 2025-2033
  • Table 4: Global: Vascular Grafts Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Vascular Grafts Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Vascular Grafts Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Vascular Grafts Market: Competitive Structure
  • Table 8: Global: Vascular Grafts Market: Key Players